Literature DB >> 12170163

Facial motion analysis with a video and computer system after treatment of acoustic neuroma.

Christopher J Linstrom1, Carol A Silverman, Douglas Colson.   

Abstract

OBJECTIVE: To objectively evaluate facial function with a computer and video system in a group of normal adults and a group of adults who have been treated for acoustic neuroma. STUDY
DESIGN: A prospective descriptive study was performed in which the experimenter performing the objective facial motion analysis was blinded to the subjective rating of facial function. PATIENTS: The normal subjects comprised 18 women and 16 men. The subjects who had been treated for acoustic neuroma included 12 patients (seven women and five men) who underwent treatment for acoustic neuroma.
METHODS: Light-reflective markers were placed at selected facial sites. A video and computer-assisted system was used to measure displacement that was unconfounded by head motion at these sites during two expressions. Proximal and remote displacement were measured for the x and y coordinates. Percentage of asymmetry relative to the total displacement was determined.
RESULTS: Significant asymmetry in displacement for the y coordinate during the eyes-closed expression occurred in 100% of the subjects who had been treated for acoustic neuroma with apparent facial dysfunction and 0% of the subjects who had been treated for acoustic neuroma with no apparent facial dysfunction. Synkinesis was severe (>0.2 cm) in 17%, moderate (0.1-0.2 cm) in 25%, mild (>95th percentile for normal subjects but <0.1 cm) in 42%, and absent in 16% of the subjects who had been treated for acoustic neuroma.
CONCLUSION: This method of objective assessment of facial function is useful in the evaluation of the asymmetry in facial motion and in the detection and quantification of synkinesis. The findings suggest that those subjective rating systems of facial function that compare the abnormal to the normal side may be confounded by compensatory motion on the presumed normal side.

Entities:  

Mesh:

Year:  2002        PMID: 12170163     DOI: 10.1097/00129492-200207000-00029

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  6 in total

1.  Comparing Patient, Casual Observer, and Expert Perception of Permanent Unilateral Facial Paralysis.

Authors:  Jacob K Dey; Lisa E Ishii; Jason C Nellis; Kofi D O Boahene; Patrick J Byrne; Masaru Ishii
Journal:  JAMA Facial Plast Surg       Date:  2017-12-01       Impact factor: 4.611

2.  Effect of Distal Masseter to Facial Nerve Transfer in Paralytic Patients with Preserved Facial Nerve Continuity on Improving Scaled Measurement of Improvement in Lip Excursion (SMILE): A Vectoral Analysis.

Authors:  Berke Özücer; Osman Halit Çam
Journal:  Turk Arch Otorhinolaryngol       Date:  2020-12-01

3.  A Bidimensional System of Facial Movement Analysis Conception and Reliability in Adults.

Authors:  Marjolaine Baude; Emilie Hutin; Jean-Michel Gracies
Journal:  Biomed Res Int       Date:  2015-06-16       Impact factor: 3.411

4.  Facial Soft-tissue Mobility: Baseline Dynamics of Patients with Unilateral Facial Paralysis.

Authors:  Carroll Ann Trotman; Julian Faraway; Tessa Hadlock; Caroline Banks; Nathan Jowett; Hyung Jae Jung
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-10-04

5.  Validation of a New Graphic Facial Nerve Grading System: FAME Scale.

Authors:  Pawan T Ojha; Shashank Nagendra; Afroz Ansari; Nikhil Dhananjay Kadam; Ajay Mathur; Neeraja Gopinathan; Nishu Ojha; Hardik Patel; Akshay Bansode; Orpah Kalel; Kishan P Morwani; Digvijay Jagtap; Sumant Kumar; Vinod Vij
Journal:  Ann Indian Acad Neurol       Date:  2022-04-06       Impact factor: 1.714

6.  Objective computerized evaluation of normal patterns of facial muscles contraction.

Authors:  Jose Jarjura Jorge; Paulo Roberto Pialarissi; Godofredo Campos Borges; Sara Agueda Fuenzalida Squella; Maria de Fátima de Gouveia; Jose Carlos Saragiotto; Victor Ribeiro Gonçalves
Journal:  Braz J Otorhinolaryngol       Date:  2012-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.